MedTrace Logo

Neurophysiologic Changes in Patients With Bipolar Depression

NCT01213121 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-11-21

No results posted yet for this study

Summary

* To examine differences in neurophysiologic parameters between unmedicated patients with bipolar depression and healthy controls
* To examine within-subject changes in neurophysiologic parameters in patients with bipolar depression treated with quetiapine

Conditions

Interventions

DRUG

Quetiapine

oral tablet/25-600mg per day/once a day/six weeks

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Jae Seung Chang, M.D., Ph.D. · Seoul National University Bundang Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2014-10-31
Completion
2015-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01213121 on ClinicalTrials.gov